Wird geladen...
Prophylaxis use among males with haemophilia B in the United States
INTRODUCTION: Prophylaxis is considered the optimal treatment for persons with moderate to severe haemophilia (factor activity between 1–5% of normal and <1% of normal respectively) in countries where safe factor concentrates are available and economically feasible. Historically, prophylactic tre...
Gespeichert in:
| Veröffentlicht in: | Haemophilia |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5724962/ https://ncbi.nlm.nih.gov/pubmed/28780772 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/hae.13317 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|